In recent issues of the Federal Register, FDA published its determinations of the regulatory review periods for the following drugs and/or medical devices: HVAD ROTARY BLOOD PUMP, OVUGEL, GATTEX, ISTENT TRABECULAR MICRO-BYPASS STENT, OSENI, SYNRIBO, COFLEX INTERLAMINAR TECHNOLOGY, and SIGNIFOR.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
